Bleakley Financial Group »

Theravance Biopharma shares owned by Bleakley Financial Group

Quarter-by-quarter ownership of Theravance Biopharma (TBPH) shares owned by Bleakley Financial Group from 13F filings

Historical chart of Bleakley Financial Group investment in Theravance Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Theravance Biopharma held by Bleakley Financial Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Theravance Biopharma by Bleakley Financial Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $141k 13k 11.24
2023-06-30 $245k 24k 10.35

More positions owned by Bleakley Financial Group

Vanguard Index Fds Large Cap Etf (VV)
Apple (AAPL)
Sprott Physical Gold & Silve Tr Unit (CEF)
Vanguard Index Fds Value Etf (VTV)
Microsoft Corporation (MSFT)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Vanguard Index Fds Mid Cap Etf (VO)
Vanguard Mun Bd Fds Tax Exempt Bd (VTEB)
Sprott Physical Gold Tr Unit (PHYS)
Ishares Tr 1 3 Yr Treas Bd (SHY)
Ishares Tr 0-3 Mnth Treasry (SGOV)
Vanguard Intl Equity Index F Tt Wrld St Etf (VT)
Amazon (AMZN)
Ishares Silver Tr Ishares (SLV)
Invesco Qqq Tr Unit Ser 1 (QQQ)

View all positions for Bleakley Financial Group

Top funds holding Theravance Biopharma

Weiss Asset Management LP[1
Madison Avenue Partners
Vanguard Group
Newtyn Management
Park West Asset Management
D. E. Shaw & Co
Bank of America Corporation
Jacobs Levy Equity Management
Jane Street
Charles Schwab Investment Management
Wellington Management Company
Goldman Sachs Group
Chescapmanager
SG Americas Securities
Highbridge Capital Management

View all funds holding Theravance Biopharma